Stocks and Investing Stocks and Investing
Mon, March 26, 2018
Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018
Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018

David Lebowitz Maintained (SNDX) at Buy with Decreased Target to $24 on, Mar 14th, 2018


Published on 2024-10-26 03:47:31 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $25 to $24 on, Mar 14th, 2018.

David has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Madhu Kumar of "B. Riley Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, January 5th, 2018